Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2026-01-09 @ 10:39 PM
Study NCT ID:
NCT01784861
Status:
TERMINATED
Last Update Posted:
2021-07-08
First Post:
2013-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
Sponsor:
Organization: